跳至主要内容
临床试验/IRCT20200304046698N2
IRCT20200304046698N2招募中3 期

Evaluation of the effectiveness of metformin prophylaxis in preventing risperidone-induced hyperprolactinemia in children and adolescents

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
10 years 至 18 years(—)
性别
All

入选标准

  • Patient and parent consent to participate in the study
  • Age 10 to 18 years
  • Psychiatric necessity for taking risperidone
  • Normal prolactin at the beginning of the study

排除标准

  • Allergy to risperidone or metformin
  • Need to change risperidone or add a second drug due to lack of control of psychiatric symptoms
  • Intolerable or severe side effects with risperidone and metformin
  • Occurrence of short-term physical symptoms of hyperprolactinemia
  • Previous or current history of neurological disease (current seizure disorders, history of head trauma, migraine)
  • Previous or current history of systemic disease (blood, endocrine, liver, thyroid, kidney, metabolic disease)
  • Smoking and any type of drug
  • Taking medication that interacts with metformin
  • Positive pregnancy test in teenage girls
  • Taking any type of drug affecting the plasma level of prolactin (including other antipsychotics, antidepressants, and stimulants)

研究者

相似试验

Evaluation of the effectiveness of metformin... | 临床试验